SITC Cancer Immunotherapy CONNECT

sitc-connect-ed-cmyk_FINAL.png

Begin your free online education today at SITC Cancer Immunotherapy connectED

SITC connectED is the new adaptive learning portal connecting users to online educational activities about cancer immunotherapy with opportunities for continuing education credits. Start with Introduction to Immunology lead by Christian Capitini, MD (University of Wisconsin).

Explore SITC connectED

 

Register now for the 32nd Annual Meeting & Pre-Conference Programs

Visit the SITC 2017 Annual Meeting website for the latest information on the premier destination for scientific exchange, education and networking in the cancer immunotherapy field.

REGISTER Today

SITC-blk.png

HOT OFF THE PRESS  

SITC members who purchase Cancer Immunotherapy Principles and Practice receive a 20 percent discount and free shipping with a promo code.*

member-ribbon-v4.png*Available only when ordering from Demos Medical Publishing

Learn More

white-out-cancer-month-920x245-bnr-v1-CIT_page_3.jpg

June is Cancer Immunotherapy Month

Support the Society for Immunotherapy of Cancer and the cancer immunotherapy field in general during Cancer Immunotherapy Month. Click here to learn all of the ways you can expand your knowledge base and help progress the field forward.

Become Involved

Non-Small Cell Lung Cancer Immunotherapy: Clinical Management

Complete this FREE online CME/CNE activity to learn more about immunotherapy for non-small cell lung cancer, then engage your patients in discussion today!

*Current as of August 2016

Earn Your Credit

2017 Advances in Cancer Immunotherapy™ – Los Angeles

Learn basic immunology principles, the mechanisms and clinical applications of immunotherapy for disease states with FDA-approved treatments and much more. Register on-site on June 29 in Los Angeles for our Advances in Cancer Immunotherapy™ program, SITC's regional cancer immunotherapy education series.

Join us in Los Angeles

sitc_log_white.png

Join the Discussion – Create a SITC Cancer Immunotherapy CONNECT Account

Learn and share information in the new SITC Cancer Immunotherapy CONNECT Open Forum! Follow a few easy steps to create a free SITC CONNECT account, upload a profile photo and join the conversation.

CREATE A SITC CONNECT ACCOUNT

Patient

Explore resources and educational opportunities for cancer patients and those who advocate for them.

Explore

 

 

 

 

Clinician

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.

Explore

 

 

 

 

Researcher

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.

Explore

 

 

 

 

Latest Discussions

  • Apart from PD-1 or CTLA-4 inhibitors being safe/effective (suggested in retrospective studies) in metastatic melanoma patients with pre--existing autoimmune disorders with manageable/reversible autoimmune flares or conventional adverse effects, careful ...

  • Which is your experience with patients with spontaneous paraneoplastic immune reaction, like a dermatomyositis leading to a diagnose of a head and neck cancer, there is experience to use immunotherapy if such a patient has a cancer recurrence after the ...

  • Hello, The attached Review Article, originally published by the American Cancer Society, should help provide answers to your question. I'd specifically point to References 7 and 8 mentioned in the article. ------------------------------ Igor Puzanov ...

Follow the SITC Twitter Feed.

 

Connect with colleagues at these Upcoming Events.

 


Ignite the Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

 

Learn More

 

Publications & Resources

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More